Prospective observational Italian study on palliative sedation in two hospice settings: Differences in casemixes and clinical care

Supportive Care in Cancer

Volumn 20, Issue 11, 2012, Pages 2829-2836

  Maltoni, Marco ^a   Miccinesi, Guido ^b,e   Morino, Piero ^c   Scarpi, Emanuela ^a   Bulli, Francesco ^b   Martini, Francesca ^d   Canzani, Filippo ^c   Dall'Agata, Monia ^a   Paci, Eugenio ^b   Amadori, Dino ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b Istituto per lo Studio e la Prevenzione Oncologica (ISPO)   (Italy)

^c Azienda Sanitaria ^*  (Italy)

^d Forlimpopoli Hospital   (Italy)

^e Cancer Prevention and Research Institute ISPO   (Italy)

Author keywords

Advanced cancer; End of life care; Hospice casemix; Palliative sedation; Survival

Indexed keywords

HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE; SEDATIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DELIRIUM; DISTRESS SYNDROME; DYSPNEA; FATIGUE; FEMALE; HOSPICE CARE; HOSPICE PATIENT; HOSPITAL ADMISSION; HUMAN; HYDRATION; INTERVENTION STUDY; ITALY; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOLOGICAL REFRACTORY PERIOD; RICHMOND AGITATION SEDATION SCALE; SEDATION; SURVIVAL RATE; SYMPTOMATOLOGY; TERMINAL CARE; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DECISION MAKING; DIAGNOSIS-RELATED GROUPS; FEMALE; HOSPICE CARE; HUMANS; HYPNOTICS AND SEDATIVES; ITALY; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; TERMINAL CARE; YOUNG ADULT;

EID: 84868482688     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1407-x     Document Type: Article

References (27)

1. Costantini M, Beccaro M, Merlo F, Study Group ISDOC (2005) The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian Survey of the Dying of Cancer (ISDOC). Palliat Med 19:628-638
2. Temel JS, Greer JA, Muzikansky A et al (2005) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733-742
3. Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F (2010) European Society for Medical Oncology (ESMO) program for the integration of Oncology and Palliative Care: a 5- year review of the Designated Centers' incentive program. Ann Oncol 21:362-369
4. Van der Heide A, Deliens L, Faisst K et al (2003) End-of-life decision-making in six European countries: descriptive studies. Lancet 362:345-350
5. De Graeff A, Dean M (2007) Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 10:67-85
6. Carr MF, Mohr GJ (2008) Palliative sedation as part of a continuum of palliative care. J Palliat Med 11:76-81
7. Maltoni M, Pittureri C, Scarpi E et al (2009) Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 20:1163-1169
8. Sykes N, Thorns A (2003) The use of opioids and sedation at the end of life. Lancet Oncol 4:312-318
9. Materstvedt LJ, Clark D, Ellershaw J et al (2003) Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force. Palliat Med 17:97-101
10. Miccinesi G, Rietjens J, Deliens L et al (2006) Continuous deep sedation: physicians' experiences in six European countries. J Pain Symptom Manag 31:122-129
11. Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10:31-38
12. Cherny NI, Radbruch L, Board of the European Association for Palliative Care (2009) European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23:581-593
13. Kirk TW, Mahon MM, Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee (2010) National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manag 39:914-923
14. van Dooren S, van Veluw HT, van Zuylen L et al (2009) Exploration of concerns of relatives during continuous palliative sedation of their family members with cancer. J Pain Symptom Manag 38:452-459
15. Morita T, Akechi T, Sugawara Y et al (2002) Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: a nationwide survey. J Clin Oncol 20:758-764
16. Schuman-Oliver Z, Brendel DH, Forstein M, Price BH (2008) The use of palliative sedation for existential distress: a psychiatric perspective. Harv Rev Psychiatr 16:339-351
17. Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observation. J Am Stat Assoc 53:457-481
18. Lawless JS (1982) Statistical models and methods for life-time data. Wiley, New York
19. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7-11
20. Porta Sales J (2001) Sedation and terminal care. Eur J Palliat Care 8:97-100
21. Peruselli C, Di Giulio P, Toscani F et al (1999) Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 13:233-241
22. Fainsinger RL, Waller A, Bercovici M et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14:257-265
23. Sessler CN, Gosnell MS, Grap J et al (2002) The Richmond Agitation-Sedation Scale. Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338-1344
24. Bruera E, Sala R, Rico MA et al (2005) Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 23:2366-2371
25. Good P, Cavenagh J, Mather M, Ravenscroft P (2008) Medically assisted hydration for palliative care patients. Cochrane Database Syst Rev (2):CD006273
26. Morita T, Tsunoda J, Inoue S, Chihara S (2001) Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manag 21:282-289
27. Morita T, Chinone Y, Ikenaga M et al (2005) Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manag 30:320-328